Motivational interviewing chatbot to help high-risk drinkers cut back on alcohol
Official title: Evaluating the Clinical Effectiveness of a Motivational Interviewing-Based Conversational Mobile Application for High-Risk Drinkers
Run by Yonsei University · NCT07238998 · Data updated 2026-11-12
This project tests whether a motivational interviewing chatbot app can help adults who drink at high risk reduce their alcohol use over four weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years to 59 Years |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Seoul, Seoul) |
| Status | Recruiting |
| Started | December 19, 2025 |
| Main results expected | November 2026 |
| Study ends | April 2027 |
| Registry record updated | May 13, 2026 |
| Trial ID | NCT07238998 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 19–59 with AUDIT scores of 8 or higher who want to reduce their drinking, can read Korean, and own and use an Android smartphone are the ideal candidates.
✕Probably not a fit
People who are pregnant or planning pregnancy, have impaired decision-making, are already in alcohol treatment or counseling, cannot use Android apps, or require more intensive medical care are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled trial using a waitlist control design to compare alcohol reduction between users of a motivational interviewing-based conversational mobile app and non-users. After screening with a clinical interview and AUDIT, 220 eligible participants will be randomized 1:1 to the intervention or control group. The intervention group will use the chatbot on an Android smartphone for four weeks with assessments at baseline, week 4, and week 16, while the control group completes the same assessments before using the app after week 16 and a final follow-up at week 20. The primary focus is the degree of alcohol reduction measured following the four-week intervention and at subsequent follow-ups.
Why it matters
Potential benefit: If successful, the app could give people an accessible, remote way to reduce harmful drinking without needing frequent clinic visits.
How similar studies have gone: Related digital brief interventions and motivational interviewing approaches have shown modest success reducing alcohol use, though fully conversational MI chatbots remain a relatively new and less-tested approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Individuals aged 19 to 59 years who are capable of providing valid written informed consent. 2. Individuals who meet the definition of high-risk drinking (AUDIT score ≥ 8).3.- Individuals who express a desire to reduce their alcohol consumption. 3. Individuals who own and use an Android smartphone (version 8 or higher). 4. Individuals who have no difficulty using mobile applications. 5. Individuals who are able to communicate adequately with the research team. 6. Individuals who fully understand the study procedures and voluntarily agree to participate. Exclusion Criteria: 1. Individuals who are unable to read or understand the consent form (e.g., illiterate individuals, non-Korean speakers). 2. Individuals with impaired decision-making capacity. 3. Pregnant individuals or those planning to become pregnant during the study period. 4. Individuals who are currently participating in another clinical study. 5. Individuals who are receiving treatment or counseling for alcohol-related problems. 6. Individuals who use two or more mobile phones. 7. Individuals who are expected to change their mobile phone or SIM card, or who plan to travel 8. abroad during the intervention period. 8. Any individual deemed inappropriate for study participation at the discretion of the investigator.
Where it's running
-
Severance Hospital
Seoul, Seoul, South Korea Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if stopping alcohol can lower blood pressure and heart risk in adults who drink and have hypertension
This study tests whether abstaining from alcohol for 8 weeks can improve blood pressure and heart-health markers in adults who regularly drink and have high blood pressure.
-
Alcohol, Breast Milk, and Metabolism in Lactating Women
This study tests whether breast tissue locally metabolizes alcohol by comparing alcohol-related markers in blood and breast milk from lactating women after low-level alcohol exposure.
-
Targeting alcohol-opioid co-use among young adults with a new mobile health tool
A mobile health app is being tested to help young adults reduce drinking and opioid use when they occur together.
-
Ketogenic Diet and Alcohol Intoxication: Can ketosis affect brain function and alcohol response
This study tests whether a 4‑week ketogenic diet changes how the brain works and how the body handles alcohol in adults who drink regularly.
-
Reset Challenge: See if 30 days without alcohol reduces high-risk drinking
This 30-day mobile program tests whether people who drink heavily can cut back or stop drinking for a month, with a focus on those in Oklahoma.
-
Acute effects of Jägerbombs with energy drinks during a binge for healthy adults
This study tests whether mixing Jägermeister with an energy drink during a binge affects intoxication, mood, coordination, and sleepiness compared with alcohol alone in healthy adults who regularly drink caffeinated beverages.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.